Nordea Investment Management Adds $137M in HCA Healthcare, Inc. ($HCA)
Key Points
- Nordea Investment Management changed its HCA Healthcare, Inc. ($HCA) stake by 33.5% last quarter, boosting to 1,447,549 shares worth $547.91 million.
- Wall Street's consensus rating on $HCA is Buy and an average price target of $503.57.
- $HCA last traded around $378.51.
Nordea Investment Management increased its position in HCA Healthcare, Inc. ($HCA) by 33.5% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,447,549 shares of HCA Healthcare, Inc. after buying 362,959 shares during the quarter. Nordea Investment Management's holdings in HCA Healthcare, Inc. were worth $547.91 million as of its most recent filing.
HCA Healthcare, Inc. ($HCA) Stock
HCA Healthcare, Inc. Earnings
HCA Healthcare, Inc. Dividend
Analysts Set New Price Targets
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.